| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 3.36 | 0.04 (+1.20%) | 2.07 - 4.05 | 680.2 thousand (Below Avg) |
Market data as of 3:01PM 05/20/13. Quotes are delayed by at least 15 min.
Avanir Pharmaceuticals Reports Fiscal 2013 Second Quarter Financial and Business Results
05/08/2013 4:01 PM ET
Avanir Pharmaceuticals Announces Date of Fiscal 2013 Second Quarter Financial Results and Conference Call
05/01/2013 8:30 AM ET
Avanir Pharmaceuticals Receives Positive CHMP Opinion for Approval of NUEDEXTA in Europe
04/26/2013 7:45 AM ET